科华智慧（深圳）创新药物研发有限公司-天然产物化合物库-创新药物研发-波谱智能解析-化合物冷冻电镜结构解析

天然产物数据库

您可快速检索70万⁺天然产物信息

检索最多: 白僵菌素大品种冬虫夏草人参三七党参大戟决明半夏丁香

CAS No.	英文名/中文名/SMILES	分子式	分子量
-	(2R,3S,4aS,8S,8aS)-7-hydroxy-6-[(1R)-1-hydroxy-2-oxo-1-phenylpropyl]-2,3-dimethyl-8-(3-methylbut-2-enyl)-8-(5-methyl-2-propan-2-ylidenehex-4-enyl)-2,3,4a,8a-tetrahydrochromene-4,5-dione - C[C@H]1[C@H](O[C@H]2[C@@H](C1=O)C(=O)C(=C([C@@]2(CC=C(C)C)CC(=C(C)C)CC=C(C)C)O)[C@](C3=CC=CC=C3)(C(=O)C)O)C	C₃₅H₄₆O₆	562.7
-	methyl 2-[(1S,3S,4aR,10aS)-4a,6,10a-trihydroxy-1-methyl-5,10-dioxo-3,4-dihydro-1H-benzo[g]isochromen-3-yl]acetate - C[C@H]1[C@]2(C(=O)C3=C(C(=CC=C3)O)C(=O)[C@]2(C[C@H](O1)CC(=O)OC)O)O	C₁₇H₁₈O₈	350.3
-	[(1R,16R,20R,21R,24S,26S,27R,35S,42R)-14-amino-30-(dihydroxymethyl)-20,24,32-trihydroxy-34-oxa-3,13,15,38-tetrazaheptacyclo[19.17.6.11,35.16,10.129,33.016,21.027,42]heptatetraconta-6(47),7,9,13,17,29(46),30,32-octaen-43-yn-26-yl] acetate - CC(=O)O[C@H]1C[C@H](CC[C@@]23C#C[C@H]4[C@H]1CC5=CC(=C(C=C5C(O)O)O)O[C@H]6CCN[C@@](C6)(CCC4)CNCCC7=CC(=CC=C7)CCN=C(N[C@@H]2C=CC[C@H]3O)N)O	C₄₅H₆₁N₅O₈	800.0
-	3-[(1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one - C[C@@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)O[C@H]2C[C@H]([C@@]3([C@@H]4[C@@H](CC[C@@]3(C2)O)[C@]5(CC[C@@H]([C@]5(C[C@H]4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O	C₂₉H₄₄O₁₂	584.7
-	(2S)-2-[(1S)-1-[(3R,8R,9R,10R,13S,14R,17S)-3-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-14,17-dihydroxy-10,13-dimethyl-1-oxo-2,3,4,7,8,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-1-hydroxyethyl]-4,5-dimethyl-2,3-dihydropyran-6-one - CC1=C(C(=O)O[C@@H](C1)[C@@](C)([C@@]2(CC[C@@]3([C@@]2(CC[C@@H]4[C@H]3CC=C5[C@@]4(C(=O)C[C@@H](C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O)C)C)O)O)O)C	C₄₀H₆₀O₁₇	812.9
-	[(1S,2S,6R,7R,8S,10R,11R,12S,14S,16R,17S,18S)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-5-oxo-14-phenyl-16-prop-1-en-2-yl-9,13,15,19-tetraoxahexacyclo[12.4.1.01,11.02,6.08,10.012,16]nonadec-3-en-17-yl] propanoate - CCC(=O)O[C@H]1[C@@H]([C@@]23[C@H]4C=C(C(=O)[C@@]4([C@H]([C@]5([C@@H]([C@@H]2[C@H]6[C@@]1(O[C@@](O6)(O3)C7=CC=CC=C7)C(=C)C)O5)CO)O)O)C)C	C₃₀H₃₄O₁₀	554.6
-	1-[[(2R,3S,6S)-3-hydroxy-6-[[5-(methoxymethyl)-1,2-oxazol-3-yl]methyl]oxan-2-yl]methyl]-3-phenyl-1-(phenylcarbamoyl)urea - COCC1=CC(=NO1)C[C@@H]2CC[C@@H]([C@H](O2)CN(C(=O)NC3=CC=CC=C3)C(=O)NC4=CC=CC=C4)O	C₂₆H₃₀N₄O₆	494.5
-	N-[[(2R,3S,6S)-3-hydroxy-6-[[5-(piperazin-1-ylmethyl)-1,2-oxazol-3-yl]methyl]oxan-2-yl]methyl]-2-phenylacetamide - C1C[C@@H]([C@H](O[C@@H]1CC2=NOC(=C2)CN3CCNCC3)CNC(=O)CC4=CC=CC=C4)O	C₂₃H₃₂N₄O₄	428.5
-	(3aR,10aS)-4-methyl-2-(1-methylpiperidin-4-yl)-1,3,3a,10a-tetrahydropyrrolo[3,4-b][1,4]benzoxazepin-5-one - CN1CCC(CC1)N2C[C@@H]3[C@H](C2)OC4=CC=CC=C4C(=O)N3C	C₁₈H₂₅N₃O₂	315.4
-	(2S,3R,4R,5R,6S)-2-[(2R,3S,4S,5S,6R)-5-hydroxy-2-[(1S,2R,4R,5'R,6R,7R,8R,9S,12R,13R,14R,16R)-16-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-14-yl]oxy-6-methyl-4-[(2S,3S,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol - C[C@@H]1CC[C@@]2([C@@H]([C@H]3[C@H](O2)C[C@H]4[C@@]3(CC[C@@H]5[C@H]4CC=C6[C@@]5([C@@H](C[C@@H](C6)O)O[C@H]7[C@H]([C@H]([C@H]([C@H](O7)C)O)O[C@H]8[C@H]([C@H]([C@H](CO8)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)OC1	C₄₄H₇₀O₁₆	855.0